| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrium | 86 | 2020 | 120 | 17.320 |
Why?
|
| Endometriosis | 53 | 2020 | 66 | 10.840 |
Why?
|
| Embryo Implantation | 31 | 2020 | 35 | 7.810 |
Why?
|
| Infertility, Female | 22 | 2019 | 27 | 5.910 |
Why?
|
| Progesterone | 22 | 2019 | 80 | 3.200 |
Why?
|
| Uterine Diseases | 9 | 2019 | 15 | 2.680 |
Why?
|
| Luteal Phase | 11 | 2016 | 22 | 2.560 |
Why?
|
| Fertilization in Vitro | 6 | 2018 | 20 | 2.410 |
Why?
|
| Pregnancy | 32 | 2020 | 815 | 2.130 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 4 | 2019 | 6 | 2.070 |
Why?
|
| Female | 111 | 2020 | 18189 | 1.940 |
Why?
|
| Abortion, Habitual | 5 | 2018 | 5 | 1.800 |
Why?
|
| Polycystic Ovary Syndrome | 7 | 2011 | 19 | 1.690 |
Why?
|
| Integrin beta3 | 6 | 2017 | 10 | 1.460 |
Why?
|
| Humans | 108 | 2020 | 29147 | 1.450 |
Why?
|
| Embryo Transfer | 4 | 2019 | 9 | 1.400 |
Why?
|
| Endometrial Neoplasms | 10 | 2017 | 34 | 1.260 |
Why?
|
| Uterus | 9 | 2018 | 73 | 1.250 |
Why?
|
| Adult | 50 | 2020 | 8441 | 1.200 |
Why?
|
| Estrogens | 9 | 2015 | 162 | 1.150 |
Why?
|
| Chorionic Gonadotropin | 4 | 2016 | 9 | 1.080 |
Why?
|
| Gene Expression Regulation | 15 | 2020 | 481 | 1.070 |
Why?
|
| Ovulation Induction | 4 | 2019 | 8 | 1.060 |
Why?
|
| Menstrual Cycle | 14 | 2017 | 36 | 1.050 |
Why?
|
| Biopsy | 9 | 2017 | 241 | 0.980 |
Why?
|
| Integrin alphaVbeta3 | 4 | 2014 | 7 | 0.880 |
Why?
|
| Receptors, Progesterone | 7 | 2018 | 45 | 0.870 |
Why?
|
| Clomiphene | 3 | 2011 | 5 | 0.860 |
Why?
|
| Pelvic Pain | 4 | 2018 | 18 | 0.850 |
Why?
|
| Reproductive Techniques, Assisted | 3 | 2019 | 5 | 0.830 |
Why?
|
| Animals | 36 | 2020 | 7300 | 0.820 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2020 | 10 | 0.800 |
Why?
|
| Immunohistochemistry | 18 | 2018 | 519 | 0.800 |
Why?
|
| Inflammation | 8 | 2020 | 508 | 0.780 |
Why?
|
| Sirtuin 1 | 2 | 2020 | 37 | 0.780 |
Why?
|
| Case-Control Studies | 15 | 2020 | 859 | 0.760 |
Why?
|
| Surrogate Mothers | 1 | 2020 | 1 | 0.760 |
Why?
|
| Reproductive Control Agents | 2 | 2016 | 2 | 0.740 |
Why?
|
| Cell Adhesion Molecules | 4 | 2014 | 45 | 0.720 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 22 | 0.700 |
Why?
|
| Pregnancy Outcome | 2 | 2016 | 52 | 0.690 |
Why?
|
| Ovarian Diseases | 1 | 2018 | 8 | 0.680 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2018 | 41 | 0.640 |
Why?
|
| Complement System Proteins | 1 | 2017 | 9 | 0.630 |
Why?
|
| Pregnancy Rate | 4 | 2019 | 10 | 0.610 |
Why?
|
| MicroRNAs | 3 | 2019 | 173 | 0.580 |
Why?
|
| Young Adult | 19 | 2020 | 2406 | 0.580 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2016 | 3 | 0.570 |
Why?
|
| Papio | 10 | 2020 | 87 | 0.560 |
Why?
|
| Stromal Cells | 9 | 2020 | 70 | 0.560 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2018 | 4 | 0.540 |
Why?
|
| Adenocarcinoma | 4 | 2015 | 301 | 0.520 |
Why?
|
| Transcription Factors | 4 | 2020 | 172 | 0.510 |
Why?
|
| Mice | 17 | 2020 | 2371 | 0.490 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2013 | 155 | 0.480 |
Why?
|
| Homeostasis | 1 | 2014 | 127 | 0.470 |
Why?
|
| Cytokines | 8 | 2019 | 243 | 0.470 |
Why?
|
| Fertility | 4 | 2017 | 22 | 0.460 |
Why?
|
| Methylene Blue | 1 | 2012 | 3 | 0.450 |
Why?
|
| Ovulation Prediction | 1 | 2012 | 1 | 0.450 |
Why?
|
| Integrins | 4 | 2010 | 20 | 0.440 |
Why?
|
| Staining and Labeling | 1 | 2012 | 56 | 0.440 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2010 | 100 | 0.440 |
Why?
|
| Transforming Growth Factor beta | 3 | 2002 | 66 | 0.440 |
Why?
|
| Signal Transduction | 10 | 2020 | 666 | 0.430 |
Why?
|
| Aromatase Inhibitors | 1 | 2012 | 7 | 0.420 |
Why?
|
| Triazoles | 1 | 2012 | 14 | 0.420 |
Why?
|
| Nitriles | 1 | 2012 | 22 | 0.420 |
Why?
|
| Adolescent | 17 | 2020 | 3257 | 0.420 |
Why?
|
| Endometrial Hyperplasia | 3 | 2009 | 14 | 0.410 |
Why?
|
| Ovulation | 1 | 2011 | 6 | 0.410 |
Why?
|
| Women's Health | 1 | 2013 | 226 | 0.410 |
Why?
|
| Prospective Studies | 7 | 2017 | 2021 | 0.410 |
Why?
|
| Neovascularization, Pathologic | 5 | 2019 | 81 | 0.400 |
Why?
|
| RNA, Messenger | 11 | 2017 | 514 | 0.400 |
Why?
|
| Sialoglycoproteins | 4 | 2003 | 7 | 0.390 |
Why?
|
| Steroids | 3 | 2006 | 36 | 0.390 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 681 | 0.370 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 2019 | 9 | 0.370 |
Why?
|
| Estrogen Receptor alpha | 3 | 2007 | 50 | 0.360 |
Why?
|
| Down-Regulation | 6 | 2017 | 143 | 0.360 |
Why?
|
| Anaphylatoxins | 1 | 2009 | 1 | 0.360 |
Why?
|
| Complement C3a | 1 | 2009 | 2 | 0.360 |
Why?
|
| Epithelial Cells | 7 | 2020 | 138 | 0.360 |
Why?
|
| Abortion, Spontaneous | 2 | 2019 | 8 | 0.350 |
Why?
|
| Laparoscopy | 5 | 2015 | 169 | 0.340 |
Why?
|
| Prunella | 1 | 2008 | 1 | 0.340 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2008 | 7 | 0.340 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2008 | 23 | 0.330 |
Why?
|
| Receptors, Vitronectin | 3 | 2002 | 4 | 0.330 |
Why?
|
| Live Birth | 2 | 2019 | 5 | 0.330 |
Why?
|
| Disease Progression | 4 | 2020 | 572 | 0.330 |
Why?
|
| Risk Factors | 5 | 2020 | 3537 | 0.320 |
Why?
|
| Retrospective Studies | 8 | 2020 | 3112 | 0.320 |
Why?
|
| Hormones | 2 | 2007 | 19 | 0.320 |
Why?
|
| Dysmenorrhea | 2 | 2018 | 3 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 980 | 0.320 |
Why?
|
| Hydrocarbons, Fluorinated | 2 | 2018 | 4 | 0.320 |
Why?
|
| Peritoneal Diseases | 2 | 2020 | 4 | 0.320 |
Why?
|
| Genital Diseases, Female | 1 | 2007 | 5 | 0.320 |
Why?
|
| Receptor, Notch1 | 2 | 2020 | 8 | 0.320 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 30 | 0.310 |
Why?
|
| Decidua | 6 | 2019 | 17 | 0.310 |
Why?
|
| Immediate-Early Proteins | 1 | 2007 | 9 | 0.310 |
Why?
|
| Killer Cells, Natural | 3 | 2014 | 24 | 0.300 |
Why?
|
| Pyrimidines | 2 | 2018 | 60 | 0.300 |
Why?
|
| Gene Expression Profiling | 7 | 2018 | 320 | 0.300 |
Why?
|
| Middle Aged | 16 | 2020 | 10846 | 0.290 |
Why?
|
| Receptors, Androgen | 3 | 2007 | 39 | 0.290 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2014 | 248 | 0.290 |
Why?
|
| Epidermal Growth Factor | 3 | 2004 | 21 | 0.290 |
Why?
|
| Cells, Cultured | 9 | 2020 | 799 | 0.280 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3105 | 0.280 |
Why?
|
| Ovarian Neoplasms | 2 | 2020 | 87 | 0.270 |
Why?
|
| Estradiol | 7 | 2015 | 118 | 0.260 |
Why?
|
| Paracrine Communication | 3 | 2019 | 8 | 0.260 |
Why?
|
| Interferon-gamma | 3 | 2018 | 51 | 0.260 |
Why?
|
| Estrogen Antagonists | 2 | 2017 | 14 | 0.250 |
Why?
|
| Apoptosis | 2 | 2016 | 337 | 0.250 |
Why?
|
| Membrane Proteins | 3 | 2017 | 256 | 0.250 |
Why?
|
| Osteopontin | 5 | 2009 | 9 | 0.250 |
Why?
|
| Proteomics | 3 | 2019 | 92 | 0.250 |
Why?
|
| Gene Expression | 3 | 2017 | 332 | 0.250 |
Why?
|
| Contraception | 1 | 2003 | 12 | 0.240 |
Why?
|
| Blotting, Western | 7 | 2014 | 281 | 0.240 |
Why?
|
| Interleukin-6 | 3 | 2020 | 225 | 0.240 |
Why?
|
| Mice, Knockout | 6 | 2018 | 425 | 0.230 |
Why?
|
| Oligopeptides | 1 | 2003 | 51 | 0.230 |
Why?
|
| Cell Line | 6 | 2020 | 450 | 0.220 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 207 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 36 | 0.220 |
Why?
|
| Luteinizing Hormone | 4 | 2014 | 18 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 249 | 0.220 |
Why?
|
| Anovulation | 1 | 2002 | 5 | 0.220 |
Why?
|
| Fertility Agents, Female | 3 | 2011 | 8 | 0.210 |
Why?
|
| Models, Biological | 4 | 2016 | 373 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 711 | 0.200 |
Why?
|
| Cell Adhesion | 4 | 2016 | 103 | 0.190 |
Why?
|
| Reproduction | 1 | 2020 | 10 | 0.190 |
Why?
|
| Galectins | 1 | 2020 | 6 | 0.190 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 136 | 0.180 |
Why?
|
| Epithelium | 3 | 2006 | 21 | 0.180 |
Why?
|
| Cystitis, Interstitial | 1 | 2020 | 37 | 0.180 |
Why?
|
| Protein Binding | 3 | 2013 | 199 | 0.180 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2019 | 1 | 0.180 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 165 | 0.170 |
Why?
|
| Leuprolide | 2 | 2009 | 8 | 0.170 |
Why?
|
| Neutrophils | 1 | 2019 | 102 | 0.170 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 8 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2019 | 61 | 0.170 |
Why?
|
| Exosomes | 1 | 2019 | 38 | 0.170 |
Why?
|
| HMGB Proteins | 1 | 2018 | 1 | 0.170 |
Why?
|
| SOXF Transcription Factors | 1 | 2018 | 4 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2017 | 22 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2012 | 92 | 0.170 |
Why?
|
| Cell Proliferation | 4 | 2019 | 573 | 0.170 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 101 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2016 | 225 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 68 | 0.170 |
Why?
|
| Dyspareunia | 1 | 2018 | 7 | 0.170 |
Why?
|
| Adrenomedullin | 1 | 2018 | 4 | 0.160 |
Why?
|
| Informed Consent | 1 | 2018 | 51 | 0.160 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 15 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2018 | 183 | 0.160 |
Why?
|
| Granulocytes | 1 | 2018 | 12 | 0.160 |
Why?
|
| Time Factors | 4 | 2018 | 2001 | 0.160 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2018 | 2 | 0.160 |
Why?
|
| Myometrium | 1 | 2018 | 11 | 0.160 |
Why?
|
| Blotting, Northern | 3 | 2002 | 26 | 0.160 |
Why?
|
| Complement Activation | 1 | 2017 | 10 | 0.160 |
Why?
|
| Choice Behavior | 1 | 2018 | 83 | 0.160 |
Why?
|
| Tristetraprolin | 1 | 2017 | 2 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2017 | 10 | 0.150 |
Why?
|
| L-Selectin | 2 | 2007 | 3 | 0.150 |
Why?
|
| Chemokines | 2 | 2018 | 35 | 0.150 |
Why?
|
| Species Specificity | 1 | 2017 | 84 | 0.150 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2017 | 4 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2017 | 159 | 0.150 |
Why?
|
| Alkaline Phosphatase | 1 | 1996 | 36 | 0.150 |
Why?
|
| Recurrence | 1 | 2017 | 235 | 0.140 |
Why?
|
| Decision Making | 1 | 2018 | 180 | 0.140 |
Why?
|
| Ascitic Fluid | 3 | 2019 | 7 | 0.140 |
Why?
|
| Regeneration | 1 | 2018 | 167 | 0.140 |
Why?
|
| Fallopian Tube Diseases | 2 | 2007 | 6 | 0.140 |
Why?
|
| Mucin-4 | 1 | 2015 | 1 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 71 | 0.130 |
Why?
|
| Follicular Phase | 1 | 2015 | 9 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 3 | 2008 | 158 | 0.130 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 1 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 142 | 0.130 |
Why?
|
| Chemokine CXCL13 | 1 | 2014 | 1 | 0.130 |
Why?
|
| Germany | 1 | 2014 | 8 | 0.130 |
Why?
|
| Interferon Regulatory Factors | 1 | 2014 | 12 | 0.130 |
Why?
|
| Neoplasm Proteins | 2 | 2007 | 141 | 0.120 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 35 | 0.120 |
Why?
|
| COUP Transcription Factor II | 1 | 2013 | 1 | 0.120 |
Why?
|
| Systems Biology | 1 | 2013 | 9 | 0.120 |
Why?
|
| Rabbits | 3 | 2003 | 185 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2004 | 40 | 0.120 |
Why?
|
| Pathology, Clinical | 1 | 2013 | 14 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 45 | 0.120 |
Why?
|
| beta Catenin | 1 | 2013 | 37 | 0.120 |
Why?
|
| Pregnancy Maintenance | 1 | 2013 | 1 | 0.120 |
Why?
|
| Embryo Loss | 1 | 2013 | 2 | 0.110 |
Why?
|
| Peritoneal Cavity | 1 | 2012 | 5 | 0.110 |
Why?
|
| Genomics | 1 | 2013 | 82 | 0.110 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 41 | 0.110 |
Why?
|
| Smoking | 1 | 2016 | 435 | 0.110 |
Why?
|
| Birth Rate | 1 | 2012 | 2 | 0.110 |
Why?
|
| Thyrotropin | 1 | 2011 | 9 | 0.110 |
Why?
|
| Prolactin | 1 | 2011 | 10 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2009 | 65 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 89 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 33 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 629 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 242 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 89 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2012 | 370 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2011 | 347 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 60 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 72 | 0.100 |
Why?
|
| Antigens, Neoplasm | 2 | 2007 | 44 | 0.100 |
Why?
|
| Plasmids | 2 | 2020 | 48 | 0.090 |
Why?
|
| Selectins | 1 | 2010 | 2 | 0.090 |
Why?
|
| North Carolina | 1 | 2014 | 1424 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 454 | 0.090 |
Why?
|
| Apolipoprotein A-I | 1 | 2009 | 68 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2018 | 504 | 0.080 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2008 | 7 | 0.080 |
Why?
|
| Pregnancy, Ectopic | 1 | 2008 | 7 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 113 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2008 | 60 | 0.080 |
Why?
|
| RNA | 2 | 2016 | 88 | 0.080 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2007 | 2 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2009 | 4 | 0.080 |
Why?
|
| Prevalence | 1 | 2010 | 900 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2009 | 5 | 0.080 |
Why?
|
| Hot Flashes | 2 | 2018 | 46 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2007 | 42 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2017 | 23 | 0.070 |
Why?
|
| Mucins | 1 | 2006 | 18 | 0.070 |
Why?
|
| Karyotyping | 1 | 2006 | 27 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2006 | 38 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2006 | 12 | 0.070 |
Why?
|
| Keratins | 1 | 2006 | 36 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 280 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2005 | 7 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2004 | 350 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2006 | 29 | 0.070 |
Why?
|
| Choristoma | 2 | 2017 | 17 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 7 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 9 | 0.070 |
Why?
|
| Gonadotropins | 1 | 2005 | 5 | 0.070 |
Why?
|
| bcl-X Protein | 1 | 2005 | 6 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2005 | 14 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 31 | 0.060 |
Why?
|
| Collagen | 3 | 2019 | 217 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 51 | 0.060 |
Why?
|
| Estrous Cycle | 1 | 2004 | 3 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 726 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 641 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 45 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 14 | 0.060 |
Why?
|
| Fallopian Tubes | 1 | 2003 | 5 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2003 | 56 | 0.060 |
Why?
|
| Isoflavones | 1 | 2003 | 65 | 0.060 |
Why?
|
| Soybean Proteins | 1 | 2003 | 64 | 0.060 |
Why?
|
| Blastocyst | 1 | 2002 | 8 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2002 | 1 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2002 | 3 | 0.060 |
Why?
|
| Growth Substances | 1 | 2002 | 7 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 37 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 1362 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2002 | 6 | 0.050 |
Why?
|
| Infertility | 1 | 2002 | 13 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 72 | 0.050 |
Why?
|
| Androgens | 1 | 2002 | 22 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2002 | 116 | 0.050 |
Why?
|
| Cell Communication | 1 | 2002 | 30 | 0.050 |
Why?
|
| Reference Values | 1 | 2002 | 224 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 145 | 0.050 |
Why?
|
| Placenta | 1 | 2002 | 63 | 0.050 |
Why?
|
| Postmenopause | 1 | 2003 | 397 | 0.050 |
Why?
|
| Left-Right Determination Factors | 1 | 2000 | 1 | 0.050 |
Why?
|
| Lipids | 2 | 2017 | 210 | 0.050 |
Why?
|
| Lentivirus | 1 | 2020 | 11 | 0.050 |
Why?
|
| Telomerase | 1 | 2020 | 21 | 0.050 |
Why?
|
| Urinary Bladder Diseases | 1 | 2020 | 18 | 0.050 |
Why?
|
| Genital Neoplasms, Female | 1 | 2020 | 15 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2019 | 9 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 39 | 0.050 |
Why?
|
| Peritoneum | 1 | 2019 | 24 | 0.050 |
Why?
|
| Transfection | 1 | 2000 | 192 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2019 | 5 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2020 | 118 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 33 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 63 | 0.040 |
Why?
|
| Observer Variation | 2 | 2013 | 96 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 14 | 0.040 |
Why?
|
| GATA2 Transcription Factor | 1 | 2018 | 1 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 1 | 0.040 |
Why?
|
| Hedgehog Proteins | 1 | 2018 | 11 | 0.040 |
Why?
|
| Indazoles | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pyridones | 1 | 2018 | 10 | 0.040 |
Why?
|
| Multigene Family | 2 | 2014 | 47 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 46 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 152 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 21 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2018 | 22 | 0.040 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2018 | 4 | 0.040 |
Why?
|
| Arginase | 1 | 2018 | 8 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2018 | 29 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2018 | 105 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2009 | 72 | 0.040 |
Why?
|
| Choriocarcinoma | 1 | 2017 | 1 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 246 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 162 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 161 | 0.040 |
Why?
|
| Protein Transport | 1 | 2017 | 74 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2017 | 49 | 0.040 |
Why?
|
| Premenopause | 1 | 2017 | 38 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 159 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 160 | 0.040 |
Why?
|
| Biological Assay | 1 | 1996 | 16 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 7 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2016 | 15 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2016 | 23 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2016 | 2 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 28 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2016 | 122 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2016 | 128 | 0.040 |
Why?
|
| Macrophages | 1 | 2018 | 188 | 0.040 |
Why?
|
| Stem Cells | 1 | 2019 | 292 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2016 | 80 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 24 | 0.030 |
Why?
|
| Chemokine CX3CL1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Bone Density | 1 | 2017 | 182 | 0.030 |
Why?
|
| Hela Cells | 1 | 2015 | 78 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2015 | 21 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 25 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 1995 | 4 | 0.030 |
Why?
|
| Pyrophosphatases | 1 | 2015 | 3 | 0.030 |
Why?
|
| Microdissection | 1 | 2015 | 3 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 533 | 0.030 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2015 | 10 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 42 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 19 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 103 | 0.030 |
Why?
|
| Monkey Diseases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 57 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2016 | 167 | 0.030 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Receptors, IgG | 1 | 2014 | 7 | 0.030 |
Why?
|
| Aged | 1 | 2007 | 9494 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 21 | 0.030 |
Why?
|
| Coculture Techniques | 2 | 2005 | 74 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 82 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 125 | 0.030 |
Why?
|
| Mifepristone | 2 | 2004 | 6 | 0.030 |
Why?
|
| Metabolomics | 1 | 2013 | 45 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 109 | 0.030 |
Why?
|
| Genome, Human | 1 | 2013 | 129 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2014 | 322 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 1362 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 7 | 0.030 |
Why?
|
| Male | 2 | 2015 | 17832 | 0.030 |
Why?
|
| Tissue Banks | 1 | 2012 | 16 | 0.030 |
Why?
|
| Immunoproteins | 1 | 2009 | 1 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 11 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 100 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2009 | 42 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 33 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 28 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 45 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 72 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 131 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 8 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2008 | 107 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2007 | 50 | 0.020 |
Why?
|
| Organ Size | 1 | 2008 | 196 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2007 | 40 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 28 | 0.020 |
Why?
|
| Leiomyoma | 1 | 2007 | 16 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 26 | 0.020 |
Why?
|
| Uterine Neoplasms | 1 | 2007 | 23 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 32 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2006 | 10 | 0.020 |
Why?
|
| Ligands | 1 | 2006 | 81 | 0.020 |
Why?
|
| Antibodies | 1 | 2006 | 53 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 97 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 9 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 129 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 787 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 864 | 0.020 |
Why?
|
| Base Sequence | 1 | 2004 | 240 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2003 | 8 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2003 | 39 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 836 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2003 | 29 | 0.010 |
Why?
|
| Peptides | 1 | 2003 | 118 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 264 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 2002 | 2 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 2002 | 10 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2002 | 7 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 55 | 0.010 |
Why?
|
| Laminin | 1 | 2002 | 13 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2002 | 29 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 39 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 473 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2002 | 34 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 97 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2002 | 86 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 98 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 1688 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 1604 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 436 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1995 | 11 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 422 | 0.010 |
Why?
|